Stocksigma LogoStocksigma Logo

Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital

Sotac Pharmaceuticals held its Extra-Ordinary General Meeting on 31st Oct'26 to seek shareholder approval for increasing its Authorised Share Capital from

Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital

Sotac Pharmaceuticals Ltd · Annual General Meeting · 31 Oct 2026, 9:38 pm

Sotac Pharmaceuticals Concludes EGM to Increase Authorised Share Capital Sotac Pharmaceuticals held its Extra-Ordinary General Meeting on 31st Oct'26 to seek shareholder approval for increasing its Authorised Share Capital from ₹11.50 cr to ₹15.00 cr. The expansion involves creating an additional 35,00,000 equity shares of ₹10 each, aggregating to ₹3.50 cr, alongside consequential alterations to Clause V of its Memorandum of Association. The capital expansion aims to enhance financial flexibility to meet future capital requirements and fund growth initiatives. Consolidated voting results scrutinized by Mittal V. Kothari & Associates will be declared within two working days.

Original exchange filing (PDF)

More announcements from Sotac Pharmaceuticals Ltd

All Sotac Pharmaceuticals Ltd announcements